Sign Up Today and Learn More About Vaxess Technologies Stock
Invest in or calculate the value of your shares in Vaxess Technologies or other pre-IPO companies through EquityZen's platform.
Vaxess Technologies Stock (VATE)
Vaxess Technologies engages in developing biomedical innovations with a focus on improving access to vaccines.
About Vaxess Technologies Stock
Founded
2012
Headquarters
Cambridge, MA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Vaxess Technologies Press Mentions
Stay in the know about the latest news on Vaxess Technologies
Vaccine formulations with increased stability
patents • Feb 08, 2025
Applicator for medicament patch
patents • Feb 08, 2025
Compositions and devices for vaccine release and uses thereof
patents • Feb 08, 2025
Vaxess Technologies Raises $12M in Funding
finsmes • Jul 04, 2024
Vaxess: $12 Million Raised To Develop Shelf-Stable MIMIX Skin Patch For Vaccines And Therapeutics
pulse2 • Jun 05, 2024
Vaxess Technologies Management
Leadership team at Vaxess Technologies
Co-Founder & CEO
Michael Schrader
Co-founder, VP of Research & Development
Kathryn Kosuda
Join now and verify your accreditation status to gain access to:
- Vaxess Technologies Current Valuation
- Vaxess Technologies Stock Price
- Vaxess Technologies Management
- Available deals in Vaxess Technologies and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Vaxess Technologies Cap Table and Funding History by Share Class and Liquidity Preferences
- Vaxess Technologies Revenue and Financials
- Vaxess Technologies Highlights
- Vaxess Technologies Business Model
- Vaxess Technologies Risk Factors
- Vaxess Technologies Research Report from SACRA Research
Trading Vaxess Technologies Stock
How to invest in Vaxess Technologies stock?
Accredited investors can buy pre-IPO stock in companies like Vaxess Technologies through EquityZen funds. These investments are made available by existing Vaxess Technologies shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Vaxess Technologies stock?
Shareholders can sell their Vaxess Technologies stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
